The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 5
  • 1
    Fletcher, Laura Margaret, Dr
    Head Of Business Development born in September 1975
    Individual (9 offsprings)
    Officer
    2021-10-13 ~ now
    OF - Director → CIF 0
  • 2
    Moore, Tanya Marie
    Senior Business Development Executive born in May 1975
    Individual (2 offsprings)
    Officer
    2021-10-15 ~ now
    OF - Director → CIF 0
  • 3
    Blundy, Keith Stuart
    Consultant born in April 1960
    Individual (4 offsprings)
    Officer
    2023-04-11 ~ now
    OF - Director → CIF 0
  • 4
    Ballis, Andreas
    Director born in July 1978
    Individual (1 offspring)
    Officer
    2021-06-02 ~ now
    OF - Director → CIF 0
    Mr Andreas Ballis
    Born in July 1978
    Individual (1 offspring)
    Person with significant control
    2021-06-02 ~ now
    PE - Ownership of shares – More than 50% but less than 75% → CIF 0
    PE - Ownership of voting rights - More than 50% but less than 75% → CIF 0
    PE - Right to appoint or remove directors → CIF 0
  • 5
    Chaltin, Patrick Christian Maurice
    Managing Director born in November 1974
    Individual (1 offspring)
    Officer
    2024-11-06 ~ now
    OF - Director → CIF 0
Ceased 2
  • 1
    Papenfuss, Kerstin, Dr
    Scientist born in May 1982
    Individual (5 offsprings)
    Officer
    2024-10-29 ~ 2024-11-30
    OF - Director → CIF 0
  • 2
    Gutteridge, Alexander Paul
    Director born in April 1979
    Individual
    Officer
    2021-06-02 ~ 2022-03-04
    OF - Director → CIF 0
    Alexander Paul Gutteridge
    Born in April 1979
    Individual
    Person with significant control
    2021-06-02 ~ 2022-03-04
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
parent relation
Company in focus

ENEDRA THERAPEUTICS LIMITED

Standard Industrial Classification
72190 - Other Research And Experimental Development On Natural Sciences And Engineering
Brief company account
Average Number of Employees
32022-07-01 ~ 2023-10-31
22021-06-02 ~ 2022-06-30
Property, Plant & Equipment
525 GBP2023-10-31
1,192 GBP2022-06-30
Fixed Assets
525 GBP2023-10-31
1,192 GBP2022-06-30
Debtors
Current
22,979 GBP2023-10-31
76 GBP2022-06-30
Cash at bank and in hand
35,135 GBP2023-10-31
26,026 GBP2022-06-30
Current Assets
58,114 GBP2023-10-31
26,102 GBP2022-06-30
Creditors
Current, Amounts falling due within one year
-112,989 GBP2023-10-31
-12,119 GBP2022-06-30
Net Current Assets/Liabilities
-54,875 GBP2023-10-31
13,983 GBP2022-06-30
Total Assets Less Current Liabilities
-54,350 GBP2023-10-31
15,175 GBP2022-06-30
Creditors
Non-current, Amounts falling due after one year
-40,000 GBP2023-10-31
-40,000 GBP2022-06-30
Net Assets/Liabilities
-94,350 GBP2023-10-31
-24,825 GBP2022-06-30
Equity
Called up share capital
91 GBP2023-10-31
91 GBP2022-06-30
Share premium
141,986 GBP2023-10-31
141,986 GBP2022-06-30
Retained earnings (accumulated losses)
-236,427 GBP2023-10-31
-166,902 GBP2022-06-30
Equity
-94,350 GBP2023-10-31
-24,825 GBP2022-06-30
Property, Plant & Equipment - Gross Cost
Computers
1,499 GBP2023-10-31
1,499 GBP2022-06-30
Property, Plant & Equipment - Accumulated Depreciation (Not Including Impairment)
Computers
307 GBP2022-06-30
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Computers, Owned/Freehold
667 GBP2022-07-01 ~ 2023-10-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Computers
974 GBP2023-10-31
Property, Plant & Equipment
Computers
525 GBP2023-10-31
1,192 GBP2022-06-30
Called-up share capital (not paid)
Current
76 GBP2023-10-31
76 GBP2022-06-30
Amount of corporation tax that is recoverable
Current
22,903 GBP2023-10-31
Other Remaining Borrowings
Current
100,000 GBP2023-10-31
Trade Creditors/Trade Payables
Current
2,581 GBP2023-10-31
Taxation/Social Security Payable
Current
1,439 GBP2023-10-31
3,159 GBP2022-06-30
Other Creditors
Current
3,169 GBP2023-10-31
6,200 GBP2022-06-30
Accrued Liabilities/Deferred Income
Current
5,800 GBP2023-10-31
2,760 GBP2022-06-30
Creditors
Current
112,989 GBP2023-10-31
12,119 GBP2022-06-30
Other Creditors
Non-current
40,000 GBP2023-10-31
40,000 GBP2022-06-30
Creditors
Non-current
40,000 GBP2023-10-31
40,000 GBP2022-06-30
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
14,342 shares2023-10-31
14,342 shares2022-06-30
Par Value of Share
Class 1 ordinary share
0.0012022-07-01 ~ 2023-10-31
  • ENEDRA THERAPEUTICS LIMITED
    Info
    Registered number 13433538
    Salisbury House, Station Road, Cambridge CB1 2LA
    Private Limited Company incorporated on 2021-06-02 (4 years 1 month). The company status is Active.
    The last date of confirmation statement was made at 2024-06-01
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

qrcode

Privacy notice

Terms and conditions

© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.